Featured Research

from universities, journals, and other organizations

Drug-resistant malaria has spread to critical border regions of Southeast Asia

Date:
July 30, 2014
Source:
Wellcome Trust
Summary:
Drug-resistant malaria parasites have spread to critical border regions of Southeast Asia, seriously threatening global malaria control and elimination programs.

Magnified 1125X, this thick film, Giemsa-stained photomicrograph revealed the presence of numerous ring-staged Plasmodium falciparum trophozoites, and a centrally-located mature schizont.
Credit: CDC/Dr. Mae Melvin

Drug-resistant malaria parasites have spread to critical border regions of Southeast Asia, seriously threatening global malaria control and elimination programmes, according to a study published in the New England Journal of Medicine.

The study confirms that resistance to the world's most effective antimalarial drug, artemisinin, is now widespread in Southeast Asia. This is not the first, or even the second time the malaria parasite has developed resistance to front line drugs, and each time resistance has emerged from the same corner of Asia on the Cambodia-Thailand border.

The study, which analysed blood samples from 1241 malaria patients in 10 countries across Asia and Africa, found that artemisinin resistance in Plasmodium falciparum -- the most deadly form of malaria-causing parasite -- is now firmly established in Western Cambodia, Thailand, Vietnam, Eastern Myanmar and Northern Cambodia. There are also signs of emerging resistance in Central Myanmar, Southern Laos and Northeastern Cambodia.

Reassuringly, there are no signs of resistance in the three African sites included in the study, located in Kenya, Nigeria and Democratic Republic of the Congo.

The study also suggests that extending the course of antimalarial treatment in areas with established resistance -- for six days rather than the standard three days -- could offer a temporary solution to this worsening problem.

"It may still be possible to prevent the spread of artemisinin resistant malaria parasites across Asia and then to Africa by eliminating them, but that window of opportunity is closing fast. Conventional malaria control approaches won't be enough -we will need to take more radical action and make this a global public health priority, without delay," said Professor Nicholas White, senior author of the study and Chairman of the Welcome Trust-funded Mahidol Oxford Tropical Medicine Research Unit (MORU), Professor of Tropical Medicine at the University of Oxford, and Chair of the Worldwide Antimalarial Resistance Network.

The study was conducted by the Tracking Resistance to Artemisinin Collaboration (TRAC) who enrolled infected adults and children at 15 trial sites in 10 malaria-endemic countries between May 2011 and April 2013. The TRAC partners examined the different responses in malaria infected patients to artemisinin treatment. Patients received a six-day antimalarial treatment, three days of an artemisinin derivative and a three day course of artemesinin combination treatment (ACT).

Patients' blood was analysed to measure the 'parasite clearance half-life' or rate at which the parasites are cleared from a patient's blood.

Results showed that the median parasite clearance half-life ranged from 1.8 hours in the Democratic Republic of the Congo to 7 hours at the Thailand-Cambodia border, where artemisinin resistance has been known about since 2005. The proportion of patients with parasites in their blood 72 hours after treatment, a widely used test for artemisinin resistance, ranged from 0% in Kenya to 68% in Eastern Thailand. Malaria infections that were slow to clear were also strongly associated with a single point mutation in a P. falciparum gene called kelch 13, an important validation of the recently discovered genetic marker (k13) in the DNA of the malaria parasite.

Researchers also found that patients who had slow clearing infections were also more likely to have parasite stages which can infect mosquitoes. This suggests that artemisinin-resistant P. falciparum parasites have a transmission advantage over parasites that are not resistant, which drives their spread.

"Frontline ACTs are still very effective at curing the majority of patients. But we need to be vigilant as cure rates have fallen in areas where artemisinin resistance is established," said Dr Elizabeth Ashley, lead scientist of the TRAC study and Clinical Researcher at the Mahidol Oxford Tropical Medicine Research Unit (MORU), University of Oxford. "Action is needed to prevent the spread of resistance from Myanmar into neighbouring Bangladesh and India."

Dr Jeremy Farrar, Director of the Wellcome Trust says: "If resistance spreads out of Asia and into Africa much of the great progress in reducing deaths from malaria will be reversed. Our ability to respond to these rapidly emerging health problems depends on swift gathering of evidence, which can be quickly translated into public health and clinical interventions that are then implemented. Antimicrobial resistance is happening now. This is not just a threat for the future, it is today's reality."

Currently over half of the world's population are at risk of malaria infection. Although there has been a substantial reduction in the number of people falling ill and dying from malaria -- with approximately 3.3 million deaths prevented since 2000 -- it is estimated that more than 600,000 people still die from the disease each year, most of them children under five years of age living in Africa.1

Whilst new antimalarial medicines are in development, and another paper published in the New England Journal of Medicine has shown some promising trial results for a potential new antimalarial drug in development at Novartis, though they are unlikely to be available for widespread distribution for several years.

"The artemisinin drugs are arguably the best antimalarials we have ever had. We need to conserve them in areas where they are still working well," concluded Dr Ashley.

Further information

  • From the late 1950s to the 1970s chloroquine resistant malaria parasites spread across Asia to Africa, resulting in a resurgence of malaria infections and millions of deaths. Chloroquine was replaced by sulphadoxine-pyrimethamine (SP), but resistance to SP also emerged in Western Cambodia and spread to Africa. SP was replaced by ACTs, and now we face the prospect of history repeating itself for a third time.
  • Artemisinin is the most effective drug against malaria. Artemisinin derivatives, such as artesunate, have several advantages over other antimalarial drugs such as chloroquine and mefloquine: the artemisinin derivatives act more rapidly and they have fewer side-effects. Although artemisinin derivatives can be used on their own -- as a monotherapy -- fears about the possible development of resistance led to recommendations that they should only be used in conjunction with one or more other drugs -- as artemisinin combination therapies (ACTs).
  • ACTs are now recommended by the World Health Organization as the firstline treatment for uncomplicated falciparum malaria, and they have contributed substantially to the recent decline in malaria cases in most tropical endemic regions.
  • Some of key drivers of resistance in the malaria parasites are counterfeit or substandard treatments, unregulated antimalarial drug use, using artemisinin without a partner antimalarial as part of a combination treatment, and the unusual genetic structure of malaria parasites in Western Cambodia.
  • The presence of kelch 13 mutations was strongly associated with a delayed parasite clearance from the patient's system during treatment, and thus has been confirmed as a reliable marker of resistance. This will facilitate surveillance efforts going forward.
  • Patients with slower parasite clearance are more likely to transmit their drug resistant strain to others.
  • Treatment failure rates with artesunate-mefloquine in Thailand and with DHA-piperaquine in Cambodia have now risen more than fivefold.

Story Source:

The above story is based on materials provided by Wellcome Trust. Note: Materials may be edited for content and length.


Journal Reference:

  1. Elizabeth A. Ashley, Mehul Dhorda, Rick M. Fairhurst, Chanaki Amaratunga, Parath Lim, Seila Suon, Sokunthea Sreng, Jennifer M. Anderson, Sivanna Mao, Baramey Sam, Chantha Sopha, Char Meng Chuor, Chea Nguon, Siv Sovannaroth, Sasithon Pukrittayakamee, Podjanee Jittamala, Kesinee Chotivanich, Kitipumi Chutasmit, Chaiyaporn Suchatsoonthorn, Ratchadaporn Runcharoen, Tran Tinh Hien, Nguyen Thanh Thuy-Nhien, Ngo Viet Thanh, Nguyen Hoan Phu, Ye Htut, Kay-Thwe Han, Kyin Hla Aye, Olugbenga A. Mokuolu, Rasaq R. Olaosebikan, Olaleke O. Folaranmi, Mayfong Mayxay, Maniphone Khanthavong, Bouasy Hongvanthong, Paul N. Newton, Marie A. Onyamboko, Caterina I. Fanello, Antoinette K. Tshefu, Neelima Mishra, Neena Valecha, Aung Pyae Phyo, Francois Nosten, Poravuth Yi, Rupam Tripura, Steffen Borrmann, Mahfudh Bashraheil, Judy Peshu, M. Abul Faiz, Aniruddha Ghose, M. Amir Hossain, Rasheda Samad, M. Ridwanur Rahman, M. Mahtabuddin Hasan, Akhterul Islam, Olivo Miotto, Roberto Amato, Bronwyn MacInnis, Jim Stalker, Dominic P. Kwiatkowski, Zbynek Bozdech, Atthanee Jeeyapant, Phaik Yeong Cheah, Tharisara Sakulthaew, Jeremy Chalk, Benjamas Intharabut, Kamolrat Silamut, Sue J. Lee, Benchawan Vihokhern, Chanon Kunasol, Mallika Imwong, Joel Tarning, Walter J. Taylor, Shunmay Yeung, Charles J. Woodrow, Jennifer A. Flegg, Debashish Das, Jeffery Smith, Meera Venkatesan, Christopher V. Plowe, Kasia Stepniewska, Philippe J. Guerin, Arjen M. Dondorp, Nicholas P. Day, Nicholas J. White. Spread of Artemisinin Resistance in Plasmodium falciparum Malaria. New England Journal of Medicine, 2014; 371 (5): 411 DOI: 10.1056/NEJMoa1314981

Cite This Page:

Wellcome Trust. "Drug-resistant malaria has spread to critical border regions of Southeast Asia." ScienceDaily. ScienceDaily, 30 July 2014. <www.sciencedaily.com/releases/2014/07/140730173145.htm>.
Wellcome Trust. (2014, July 30). Drug-resistant malaria has spread to critical border regions of Southeast Asia. ScienceDaily. Retrieved September 30, 2014 from www.sciencedaily.com/releases/2014/07/140730173145.htm
Wellcome Trust. "Drug-resistant malaria has spread to critical border regions of Southeast Asia." ScienceDaily. www.sciencedaily.com/releases/2014/07/140730173145.htm (accessed September 30, 2014).

Share This



More Health & Medicine News

Tuesday, September 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

How 'Yes Means Yes' Defines Sexual Assault

How 'Yes Means Yes' Defines Sexual Assault

Newsy (Sep. 29, 2014) Aimed at reducing sexual assaults on college campuses, California has adopted a new law changing the standard of consent for sexual activity. Video provided by Newsy
Powered by NewsLook.com
Scientists May Have Found An Early Sign Of Pancreatic Cancer

Scientists May Have Found An Early Sign Of Pancreatic Cancer

Newsy (Sep. 29, 2014) Researchers looked at 1,500 blood samples and determined people who developed pancreatic cancer had more branched chain amino acids. Video provided by Newsy
Powered by NewsLook.com
Colo. Doctors See Cluster of Enterovirus Cases

Colo. Doctors See Cluster of Enterovirus Cases

AP (Sep. 29, 2014) Doctors at the Children's Hospital of Colorado say they have treated over 4,000 children with serious respiratory illnesses since August. Nine of the patients have shown distinct neurological symptoms, including limb weakness. (Sept. 29) Video provided by AP
Powered by NewsLook.com
Dr.'s Unsure of Cause of Fast-Spreading Virus

Dr.'s Unsure of Cause of Fast-Spreading Virus

AP (Sep. 29, 2014) Doctors at the Children's Hospital of Colorado say they have treated over 4,000 children with serious respiratory illnesses since August. Nine of the patients have shown distinct neurological symptoms, including limb weakness. (Sept. 29) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins